2014
DOI: 10.1136/archdischild-2014-306576.212
|View full text |Cite
|
Sign up to set email alerts
|

PC.111 Survey of Sildenafil Use for Treatment of Persistent Pulmonary Hypertension (PPHN) in Tertiary Neonatal Intensive Care Units (NICU) in England and Wales

Abstract: Introduction Sildenafil is increasingly used to treat PPHN secondary to chronic lung disease in neonates. Severity of PPHN has been linked to increased mortality at two years.1 There is no national guideline advising clinicians on dosage or weaning schedules for use of Sildenafil in neonates. Methods A telephone survey of tertiary level neonatal units in England and Wales (n = 48) was conducted in December 2013 and January 2014. Neonatal consultants were contacted to ensure robust data. In the event a consul… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles